Skip to content

Comparison of effect of abutment removal and reconnection on increasing inflammatory factors around dental implants in multi-unit abutment with conventional abutment

Comparison of effect of abutment removal and reconnection on increasing inflammatory factors around dental implants in multi-unit abutment with conventional abutment

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016071120488N2
Enrollment
50
Registered
2016-08-15
Start date
2016-05-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

implantitis. Unspecified complication of internal prosthetic device, implant and graft

Interventions

Intervention 1: Intervention1: In on side multi-unit abutment will be used. Intervention 2: Intervention2: In another side, common abutment will be used.
Treatment - Devices
Intervention1: In on side multi-unit abutment will be used.
Intervention2: In another side, common abutment will be used.

Sponsors

Vice Chancellor for Research and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 139 Years

Inclusion criteria

Inclusion criteria: • Inclusion criteria of the study: Having informed consent for inclusion to study; Having at least two units of the posterior dental titanium implants in two-sided at the same jaw; Putting implants under two-stage process that demands exposure in the second stage of surgery; Having at least 2 mm attached gingiva around the implant; 5.Maximum thickness of gingiva in the neck of the implant to be 3 mm; Having at least 18 years-old • Exclusion criteria of the study: Scaling and Root planning in the past three months; People who need bone augmentation and with periodontitis; People who underwent radiotherapy within the past year in the head and neck areas; Pregnant women and nursing mothers; Patients receiving antibiotics in the past 6 months; Having any systemic diseases like diabetes that affect on oral health; Drug addiction, smoking or alcohol; A history of the use of the bisphosphonates; Taking systemic anti-inflammatory medications

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
IL6 - IL1ß. Timepoint: befor intervention- 4 month after intervention. Method of measurement: ELISA Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ramin Negahdari

Tabriz university of medical sciences

negahdarir@tbzmed.ac.ir+98 41 3440 9387

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026